Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,267 JPY | -1.18% | +1.25% | +27.07% |
Business Summary
Number of employees: 747
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
88.6
%
| 50,791 | 89.7 % | 53,579 | 88.6 % | +5.49% |
Animal Health
11.0
%
| - | - | 6,660 | 11.0 % | - |
Others
0.4
%
| 5,816 | 10.3 % | 220 | 0.4 % | -96.22% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 56,607 | 100.0 % | 60,461 | 100.0 % | +6.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
President | 72 | 01/21/01 | |
Kiyohiko Tamura
ADM | Chief Administrative Officer | - | - |
Kunihiro Gunji
CMP | Compliance Officer | - | 01/21/01 |
Director/Board Member | - | - | |
Maiko Mori
BRD | Director/Board Member | - | - |
Ikuo Kumano
AUD | Comptroller/Controller/Auditor | 66 | 01/21/01 |
Yuichiro Fukui
AUD | Comptroller/Controller/Auditor | 64 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
President | 72 | 01/21/01 | |
Atsushi Maruo
BRD | Director/Board Member | 65 | 01/21/01 |
Director/Board Member | 75 | 01/21/01 | |
Yuichiro Fukui
AUD | Comptroller/Controller/Auditor | 64 | 01/21/01 |
Sota Yamaguchi
BRD | Director/Board Member | 40 | 01/21/01 |
Ikuo Kumano
AUD | Comptroller/Controller/Auditor | 66 | 01/21/01 |
Maiko Mori
BRD | Director/Board Member | - | - |
Director/Board Member | - | - | |
Director/Board Member | - | 27/23/27 | |
Koji Enokido
BRD | Director/Board Member | - | 27/23/27 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
2,231,900 | 7.30% | 32,723,828 $ | |
HA TAY PHARMACEUTICAL 22.36% | 18,411,178 | 22.36% | 19,974,287 $ |
OSAKA SODA CO., LTD. 1.00% | 266,000 | 1.00% | 16,978,163 $ |
1,406,705 | 0.01% | 14,471,829 $ | |
INABATA & CO.,LTD. 1.08% | 606,000 | 1.08% | 12,713,007 $ |
YAKULT HONSHA CO.,LTD. 0.11% | 360,000 | 0.11% | 7,419,074 $ |
374,000 | 0.70% | 5,268,545 $ | |
235,000 | 0.54% | 4,579,041 $ | |
500,000 | 0.03% | 3,534,970 $ | |
71,000 | 0.25% | 2,993,029 $ |
Company contact information
ASKA Pharmaceutical Holdings Co., Ltd.
2-5-1 Shibaura Minato-Ku
108-8532, Tokyo
+
http://www.aska-pharma-hd.co.jpSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.07% | 412M | |
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B |
- Stock Market
- Equities
- 4886 Stock
- Company ASKA Pharmaceutical Holdings Co.,Ltd.